July 23 (Reuters) - Mesoblast Ltd (MSB) :
- FDA ACCEPTS MESOBLAST’S BIOLOGICS LICENSE APPLICATION (BLA) FOR RYONCIL® IN CHILDREN WITH STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE (SR-AGVHD)
- MESOBLAST LTD - MESOBLAST ANTICIPATES A DECISION ON OR BEFORE FDA'S PRESCRIPTION DRUG USER FEE ACT (PDUFA) GOAL DATE OF JANUARY 7, 2025.
- Forums
- ASX - By Stock
- News: MSB FDA Accepts Mesoblast’S Biologics License Application For Ryoncil®
July 23 (Reuters) - Mesoblast Ltd (MSB) : FDA ACCEPTS...
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.31 |
Change
0.150(13.0%) |
Mkt cap ! $1.490B |
Open | High | Low | Value | Volume |
$1.15 | $1.33 | $1.15 | $25.26M | 19.99M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 161000 | $1.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.31 | 50400 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 161000 | 1.300 |
6 | 101986 | 1.295 |
6 | 226866 | 1.290 |
4 | 70613 | 1.285 |
5 | 137074 | 1.280 |
Price($) | Vol. | No. |
---|---|---|
1.310 | 50400 | 2 |
1.315 | 2007 | 1 |
1.320 | 40992 | 3 |
1.325 | 20772 | 3 |
1.330 | 139522 | 8 |
Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online